Metastatic Colon Cancer Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00032110Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerTreatment